Natco Pharma declines after recent sharp rally

Natco Pharma lost 3.73% to Rs 743.80 at 11:01 IST on BSE, with the stock sliding on profit booking after recent rally.

Meanwhile, the S&P BSE Sensex was down 233 points, or 0.73% at 31,562.46.

On the BSE, 17,000 shares were traded on the counter so far as against the average daily volumes of 73,385 shares in the past one quarter. The stock had hit a high of Rs 774.70 and a low of Rs 742.10 so far during the day. The stock had hit a record high of Rs 1,080 on 9 June 2017 and a 52-week low of Rs 495 on 9 November 2016.

The stock had underperformed the market over the past one month till 17 Aug 2017, declining 21.58% compared with the Sensex's 0.87% fall. The scrip had also underperformed the market over the past one quarter declining 19.32% as against the Sensex's 3.71% rise. The scrip had, however, outperformed the market over the past one year advancing 20% as against the Sensex's 13.53% rise.

The large-cap company has equity capital of Rs 34.86 crore. Face value per share is Rs 2.

Shares Natco Pharma had rallied 10.9% in the preceding four trading sessions to settle at Rs 772.60 yesterday, 17 August 2017, from its close of Rs 696.65 on 10 August 2017.

Natco Pharma's consolidated net profit spurted 97.1% to Rs 94 crore on 31.6% increase in net sales to Rs 428.10 crore in Q1 June 2017 over Q1 June 2016.

Natco Pharma manufactures generic dosage forms, bulk actives and intermediates for the Indian and international markets.

Powered by Capital Market - Live News